Immunicums MERECA-studie utvald för muntlig presentation vid ASCO-SITC Clinical Immuno-Oncology Symposium

NEXT STORY
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma
PREV STORY
Worldwide Cell Analysis Market Insights, 2019-2024: Pharmaceutical & Biotechnology Companies and CROs Set to Exhibit the Highest Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myriad Announces New GeneSight® Study Published in Personalized Medicine

Study based upon OptumInsight data showed More Than $6,200 in First Year Healthcare Costs ...

author_avatar
NASDAQ Market News

Enlivex Therapeutics Announces Positive Interim Safety and Efficacy Data From Ongoing Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis

author_avatar
NASDAQ Market News

RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors

Houston, TX (USA) and Courbevoie (France), Jan. 10, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. ...

author_avatar
NASDAQ Market News